Saldanha, E. F., Clement, K., Carlsson, L., Knox, J. J., Grant, R. C., Wang, X., Tsang, E. S., Spreafico, A., Razak, A. R. A., Salawu, A., Elimova, E., Bedard, P., Zhang, T., Feilotter, H., Siu, L. L. (2026). Clinical utility of liquid
                    <i>KRAS</i>
                    -mutation screening in advanced pancreatic cancer patients referred for early-phase trials.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3049